The role of IL-17 in the treatment of psoriatic arthritis.

about

Consensus on the management of patients with psoriatic arthritis in a dermatology setting.

P2860

Q50002313-09E79479-9F12-427B-8A43-DE9954F670AE

P2860

The role of IL-17 in the treatment of psoriatic arthritis.

Item

http://www.wikidata.org/entity/Q39293096

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The role of IL-17 in the treatment of psoriatic arthritis.

@en

The role of IL-17 in the treatment of psoriatic arthritis.

@nl

type

Item

label

The role of IL-17 in the treatment of psoriatic arthritis.

@en

The role of IL-17 in the treatment of psoriatic arthritis.

@nl

prefLabel

The role of IL-17 in the treatment of psoriatic arthritis.

@en

The role of IL-17 in the treatment of psoriatic arthritis.

@nl

P1476

The role of IL-17 in the treatment of psoriatic arthritis.

@en

P2093

Ennio Lubrano

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and signalling in the IL-17 receptor family

Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways

Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris

Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis

Interleukin-17 family and IL-17 receptors

Interleukin-17 and type 17 helper T cells

Interleukin-17 family members and inflammation

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, pla

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phas

P304

815-821

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1744666X.2017.1327354

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fabio Massimo Perrotta

P577

2017-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28485176

http://www.w3.org/2001/XMLSchema#string

The role of IL-17 in the treatment of psoriatic arthritis.

about

P2860

P2860

The role of IL-17 in the treatment of psoriatic arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698